$ORGO
Organogenesis Holdings Inc.

2024 Q2 Form 10-Q Financial Statement

#000095017024057050 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $130.2M $110.0M
YoY Change 11.01% 2.17%
Cost Of Revenue $29.20M $28.70M
YoY Change 10.95% 7.85%
Gross Profit $101.0M $81.28M
YoY Change 11.03% 0.3%
Gross Profit Margin 77.58% 73.91%
Selling, General & Admin $76.54M $72.32M
YoY Change 8.85% -2.05%
% of Gross Profit 75.76% 88.98%
Research & Development $15.59M $12.81M
YoY Change 42.5% 14.35%
% of Gross Profit 15.43% 15.76%
Depreciation & Amortization $3.366M $3.072M
YoY Change 51.08% 14.03%
% of Gross Profit 3.33% 3.78%
Operating Expenses $114.9M $85.13M
YoY Change 41.44% 0.11%
Operating Profit -$13.89M -$3.852M
YoY Change -242.56% -3.72%
Interest Expense $620.0K $514.0K
YoY Change 4.38% -20.8%
% of Operating Profit
Other Income/Expense, Net -$648.0K -$491.0K
YoY Change 14.49% -21.57%
Pretax Income -$14.54M -$4.343M
YoY Change -258.41% -6.14%
Income Tax $2.503M -$2.243M
% Of Pretax Income
Net Earnings -$17.04M -$2.100M
YoY Change -420.6% -29.27%
Net Earnings / Revenue -13.09% -1.91%
Basic Earnings Per Share -$0.13 -$0.02
Diluted Earnings Per Share -$0.13 -$0.02
COMMON SHARES
Basic Shares Outstanding 132.6M 132.0M
Diluted Shares Outstanding 132.6M 131.9M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.90M $88.63M
YoY Change 1.11% -0.08%
Cash & Equivalents $89.90M $88.63M
Short-Term Investments
Other Short-Term Assets $11.46M $14.70M
YoY Change 34.25% 39.09%
Inventory $26.88M $27.69M
Prepaid Expenses
Receivables $105.9M $96.15M
Other Receivables $0.00 $0.00
Total Short-Term Assets $234.2M $227.2M
YoY Change 8.21% 4.77%
LONG-TERM ASSETS
Property, Plant & Equipment $89.95M $114.2M
YoY Change -19.56% 7.13%
Goodwill $28.77M $28.77M
YoY Change 0.0% 0.0%
Intangibles $14.14M $14.97M
YoY Change -22.88% -23.47%
Long-Term Investments
YoY Change
Other Assets $5.851M $6.709M
YoY Change 320.03% 358.58%
Total Long-Term Assets $209.0M $231.3M
YoY Change -10.65% 0.88%
TOTAL ASSETS
Total Short-Term Assets $234.2M $227.2M
Total Long-Term Assets $209.0M $231.3M
Total Assets $443.2M $458.5M
YoY Change -1.59% 2.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.39M $23.23M
YoY Change 7.3% -23.36%
Accrued Expenses $38.02M $39.76M
YoY Change 36.83% 39.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.883M $6.592M
YoY Change 20.99% 31.6%
Total Short-Term Liabilities $85.73M $82.80M
YoY Change 16.71% 8.84%
LONG-TERM LIABILITIES
Long-Term Debt $59.05M $60.98M
YoY Change -7.58% -5.99%
Other Long-Term Liabilities $1.268M $1.242M
YoY Change 6.55% 8.47%
Total Long-Term Liabilities $1.268M $1.242M
YoY Change 6.55% 8.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.73M $82.80M
Total Long-Term Liabilities $1.268M $1.242M
Total Liabilities $179.7M $180.5M
YoY Change 0.35% -1.07%
SHAREHOLDERS EQUITY
Retained Earnings -$60.11M -$43.07M
YoY Change 37.97% -11.89%
Common Stock $323.6M $321.1M
YoY Change 2.78% 2.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $263.5M $278.0M
YoY Change
Total Liabilities & Shareholders Equity $443.2M $458.5M
YoY Change -1.59% 2.77%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$17.04M -$2.100M
YoY Change -420.6% -29.27%
Depreciation, Depletion And Amortization $3.366M $3.072M
YoY Change 51.08% 14.03%
Cash From Operating Activities $4.738M -$10.16M
YoY Change -45.2% 100.16%
INVESTING ACTIVITIES
Capital Expenditures $1.880M $2.222M
YoY Change -74.93% -70.62%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.880M -$2.222M
YoY Change -74.93% -70.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.727M -2.608M
YoY Change 63.85% 111.0%
NET CHANGE
Cash From Operating Activities 4.738M -10.16M
Cash From Investing Activities -1.880M -2.222M
Cash From Financing Activities -1.727M -2.608M
Net Change In Cash 1.131M -14.99M
YoY Change 1116.13% 8.05%
FREE CASH FLOW
Cash From Operating Activities $4.738M -$10.16M
Capital Expenditures $1.880M $2.222M
Free Cash Flow $2.858M -$12.38M
YoY Change 149.17% -2.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001661181
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-37906
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
ORGANOGENESIS HOLDINGS INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1329150
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
85 Dan Road
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Canton
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02021
CY2024Q1 dei City Area Code
CityAreaCode
781
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
575-0775
CY2024Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
ORGO
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132572465
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88626000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103840000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
720000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
498000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96148000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81999000
CY2024Q1 us-gaap Inventory Net
InventoryNet
27694000
CY2023Q4 us-gaap Inventory Net
InventoryNet
28253000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13979000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10454000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
227167000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
225044000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114245000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116228000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14970000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15871000
CY2024Q1 us-gaap Goodwill
Goodwill
28772000
CY2023Q4 us-gaap Goodwill
Goodwill
28772000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38616000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
40118000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28002000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28002000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6709000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5990000
CY2024Q1 us-gaap Assets
Assets
458481000
CY2023Q4 us-gaap Assets
Assets
460025000
CY2024Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
5489000
CY2023Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
5486000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1103000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1081000
CY2024Q1 orgo Current Portion Of Operating Lease Obligations Related Party
CurrentPortionOfOperatingLeaseObligationsRelatedParty
8543000
CY2023Q4 orgo Current Portion Of Operating Lease Obligations Related Party
CurrentPortionOfOperatingLeaseObligationsRelatedParty
8413000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4675000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4731000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
23230000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
30724000
CY2024Q1 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
39759000
CY2023Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
30074000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
82799000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80509000
CY2024Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
59371000
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
60745000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1604000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1888000
CY2024Q1 orgo Operating Lease Liability Noncurrent Related Party
OperatingLeaseLiabilityNoncurrentRelatedParty
11052000
CY2023Q4 orgo Operating Lease Liability Noncurrent Related Party
OperatingLeaseLiabilityNoncurrentRelatedParty
11954000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24383000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25053000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1242000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1213000
CY2024Q1 us-gaap Liabilities
Liabilities
180451000
CY2023Q4 us-gaap Liabilities
Liabilities
181362000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
133267888
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132044944
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132539340
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131316396
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
13000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
321088000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
319621000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43071000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40971000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
278030000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278663000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
458481000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
460025000
CY2024Q1 us-gaap Revenues
Revenues
109976000
CY2023Q1 us-gaap Revenues
Revenues
107642000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
28696000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
26607000
CY2024Q1 us-gaap Gross Profit
GrossProfit
81280000
CY2023Q1 us-gaap Gross Profit
GrossProfit
81035000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72322000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73834000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12810000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11202000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
85132000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
85036000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3852000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4001000
CY2024Q1 us-gaap Interest Expense
InterestExpense
514000
CY2023Q1 us-gaap Interest Expense
InterestExpense
649000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-491000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-626000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4343000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4627000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2243000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1658000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2100000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2969000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131861772
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131861772
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131083841
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131083841
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
278663000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
180000
CY2024Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1120000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2407000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2100000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
278030000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
265669000
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-298000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1914000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2969000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
263701000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2100000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2969000
CY2024Q1 us-gaap Depreciation
Depreciation
3072000
CY2023Q1 us-gaap Depreciation
Depreciation
2694000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
901000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1230000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2203000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1939000
CY2024Q1 orgo Non Cash Interest Expense
NonCashInterestExpense
105000
CY2023Q1 orgo Non Cash Interest Expense
NonCashInterestExpense
107000
CY2024Q1 orgo Deferred Interest Expense
DeferredInterestExpense
122000
CY2023Q1 orgo Deferred Interest Expense
DeferredInterestExpense
122000
CY2024Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
968000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
243000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-347000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-63000
CY2024Q1 orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-2515000
CY2023Q1 orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-1407000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2407000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1914000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15117000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3429000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4670000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2163000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4315000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4774000
CY2024Q1 orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
2199000
CY2023Q1 orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
2122000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4391000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1390000
CY2024Q1 orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
9962000
CY2023Q1 orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
2029000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
28000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
22000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10162000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5077000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2222000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7562000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2222000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7562000
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1406000
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
938000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1120000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
298000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
180000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
262000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2608000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1236000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14992000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13875000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104338000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103290000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89346000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89415000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1375000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1271000
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
35000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
128000
CY2023Q1 orgo Cumulative Effect Adjustment For Adoption
CumulativeEffectAdjustmentForAdoption
615000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
786000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1986000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
701000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1586000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported results of operations during the reporting periods. In preparing the condensed consolidated financial statements, the estimates and assumptions that management considers to be significant and that present the greatest amount of uncertainty include: revenue recognition; sales returns and credit losses; inventory reserve; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets; and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the valuation and recognition of stock-based compensation. Actual results and outcomes may differ significantly from those estimates and assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. The Company invests its cash equivalents in highly rated money market funds. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (“FDIC”). However, the Company sweeps cash daily overnight and diversifies among financial institutions to reduce such exposure.</span></p>
CY2023Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5273000
CY2023Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
5273000
CY2024Q1 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1394000
CY2023Q1 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1424000
CY2024Q1 us-gaap Revenues
Revenues
109976000
CY2023Q1 us-gaap Revenues
Revenues
107642000
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
103623000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
88859000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7475000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6860000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96148000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81999000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6860000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6362000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
968000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
243000
CY2024Q1 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-356000
CY2023Q1 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-299000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
3000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7475000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6921000
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13341000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12988000
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
858000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
810000
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13495000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14455000
CY2024Q1 us-gaap Inventory Net
InventoryNet
27694000
CY2023Q4 us-gaap Inventory Net
InventoryNet
28253000
CY2024Q1 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
2515000
CY2023Q1 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
1407000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
130600000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
130347000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
74745000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73186000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114245000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
116228000
CY2024Q1 us-gaap Depreciation
Depreciation
3072000
CY2023Q1 us-gaap Depreciation
Depreciation
2694000
CY2024Q1 us-gaap Goodwill
Goodwill
28772000
CY2023Q4 us-gaap Goodwill
Goodwill
28772000
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
43553000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14970000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42652000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15871000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
901000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1230000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24078000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18287000
CY2024Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6582000
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3075000
CY2024Q1 orgo Accrued But Unpaid Lease Obligations And Interest Current
AccruedButUnpaidLeaseObligationsAndInterestCurrent
2448000
CY2023Q4 orgo Accrued But Unpaid Lease Obligations And Interest Current
AccruedButUnpaidLeaseObligationsAndInterestCurrent
2326000
CY2024Q1 orgo Accrued Milestone Payment Current
AccruedMilestonePaymentCurrent
2500000
CY2023Q4 orgo Accrued Milestone Payment Current
AccruedMilestonePaymentCurrent
2500000
CY2024Q1 orgo Accrued Option Payment
AccruedOptionPayment
2500000
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
483000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2799000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1168000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1087000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39759000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30074000
CY2023Q1 orgo Number Of Reduction In Employees
NumberOfReductionInEmployees
71
CY2023Q1 orgo Percentage Of Reduction In Employees
PercentageOfReductionInEmployees
0.07
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
1817000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1908000
CY2024Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
280000
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
904000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
904000
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
624000
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
280000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1192000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
1908000
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
2013000
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
1087000
CY2024Q1 us-gaap Secured Debt
SecuredDebt
65156000
CY2023Q4 us-gaap Secured Debt
SecuredDebt
66563000
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
296000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
332000
CY2024Q1 orgo Secured Debt Net
SecuredDebtNet
64860000
CY2023Q4 orgo Secured Debt Net
SecuredDebtNet
66231000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4218000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6563000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
54375000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
65156000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9340046
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.6
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M28D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10267000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2640601
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.43
CY2024Q1 orgo Share Based Compensation Arrangement By Share Based Payment Award Options Total Exercised Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsTotalExercisedNumberOfShares
152250
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.18
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
254000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
21738
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.85
CY2024Q1 orgo Share Based Compensation Arrangement By Share Based Payment Award Options Canceled And Forfeited In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledAndForfeitedInPeriodIntrinsicValue
7000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11806659
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.38
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M10D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3359000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5258648
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.92
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M4D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2487000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10457197
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.47
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y10D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
3169000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2640601
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3554528
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2100000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2969000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131861772
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131861772
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131083841
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131083841
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2448000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2326000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
288000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
57000
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0
CY2024Q1 orgo Finance Lease Cost
FinanceLeaseCost
345000
CY2023Q1 orgo Finance Lease Cost
FinanceLeaseCost
0
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2203000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2291000
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
661000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
758000
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1126000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1794000
CY2024Q1 us-gaap Lease Cost
LeaseCost
4335000
CY2023Q1 us-gaap Lease Cost
LeaseCost
4843000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
3454000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
3454000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
767000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
479000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2687000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2975000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2715000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2468000
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
57000
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
0
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
262000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
CY2024Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M29D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M29D
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M21D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y5M26D
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0791
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0791
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0475
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0471
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7580000
CY2024Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
959000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
8819000
CY2024Q1 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
1278000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
7657000
CY2024Q1 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
737000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
8119000
CY2024Q1 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
0
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
3580000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
15108000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
50863000
CY2024Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2974000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7483000
CY2024Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
267000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
43380000
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
2707000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.511
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2243000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1658000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-057050-index-headers.html Edgar Link pending
0000950170-24-057050-index.html Edgar Link pending
0000950170-24-057050.txt Edgar Link pending
0000950170-24-057050-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orgo-20240331.htm Edgar Link pending
orgo-20240331.xsd Edgar Link pending
orgo-ex31_1.htm Edgar Link pending
orgo-ex31_2.htm Edgar Link pending
orgo-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
orgo-20240331_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable